Rivaroxaban and false positive lupus anticoagulant testing

Thrombosis and Haemostasis

Volumn 105, Issue 2, 2011, Pages 385-386

  Merriman, Eileen ^a   Kaplan, Zane ^a   Butler, Jenny ^a   Malan, Erica ^a   Gan, Eng ^a   Tran, Huyen ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LUPUS ANTICOAGULANT; RIVAROXABAN;

CLINICAL TRIAL; DRUG EFFECT; FALSE POSITIVE RESULT; HUMAN; LETTER; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOPLASTIN TIME; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FALSE POSITIVE REACTIONS; HUMANS; LUPUS COAGULATION INHIBITOR; MORPHOLINES; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; PROTHROMBIN TIME; THIOPHENES; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 79851471020     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-08-0511     Document Type: Letter

References (7)

1. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737-1740.
2. Greaves M, Cohen H, MacHin SJ, et al. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704-715. (Pubitemid 30609746)
3. Tripodi A. Testing for lupus anticoagulants: all that a clinician should know. Lupus 2009; 18: 291-298.
4. Genzen JR, Miller JL. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing. Am J Clin Pathol 2005; 124: 586-593. (Pubitemid 41395640)
5. Gosselin RC, King JH, Janatpur KA, et al. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing. Arch Pathol Lab Med 2004; 128: 1142-1145. (Pubitemid 39313368)
6. Lambert M, Ferrard-Sasson G, Dubucquoi S, et al. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population. Thromb Haemost 2009; 101: 577-581.
7. Samama MM, Martinoli JL, LeFlem L, et al. Assessment of laboratory assays to measure rivaroxaban - an oral, direct factor Xa inhibitor. Thromb Haemost 2010; 103: 815-825